CORONARY SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR RELEASE IS A BIOMARKER OF ENDOTHELIAL-DEPENDENT MICROVASCULAR DYSFUNCTION

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2018)

引用 0|浏览12
暂无评分
摘要
Soluble Urokinase Plasminogen Activator Receptor (suPAR) is a pro-inflammatory biomarker associated with immune activation and fibrinolysis inhibition. suPAR, coronary epicardial endothelial dysfunction (ED) and endothelial-dependent microvascular dysfunction (MD) have been associated with adverse
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要